An attempt to change the grandfather date in the FDA’s deeming regulations will not be taken up in the current lame-duck session of the U.S. Congress, a key law-maker in that effort said Thursday. ...
Restricted content. Do you want to read more?
Register
Sign up NOW for 7 days FREE TRIAL and access our briefings section
